Search Tag: Leap Therapeutics
2022 06 Sep
Leap Therapeutics, Inc., a biotechnology company focused on developing targeted and immuno-oncology therapeutics announced the appointment of Richard L. Schilsky, MD, FASCO, FACP, FSCT to its Board of Directors, effective September 1, 2022. Dr. Schilsky brings over 40 years of experience in medicine and clinical research, specializing in new drug...Read more